|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/198 | (2006.01) |
| A61K 31/198 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61P 5/14 | (2006.01) | ||
| A61P 5/14 | (2018.01) | ||
| A61K 9/0095 | (2013.01) |
| (11) | Number of the document | 3930703 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20705746.4 |
| Date of filing the European patent application | 2020-02-25 | |
| (97) | Date of publication of the European application | 2022-01-05 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/054873 |
| Date | 2020-02-25 |
| (87) | Number | WO 2020/178074 |
| Date | 2020-09-10 |
| (30) | Number | Date | Country code |
| 201900003013 | 2019-03-01 | IT |
| (72) |
FOSSATI, Tiziano , CH
MAUTONE, Giuseppe , CH
SCARSI, Claudia , CH
|
| (73) |
Altergon S.A. ,
Via Dogana Vecchia 2, 6900 Lugano,
CH
|
| (54) | ADMINISTRATION REGIMEN OF SOLUTIONS OF T4 THYROID HORMONE WITH HIGH ORAL ABSORPTION |
| ADMINISTRATION REGIMEN OF SOLUTIONS OF T4 THYROID HORMONE WITH HIGH ORAL ABSORPTION |